Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 2
2007 3
2009 5
2010 3
2011 1
2012 3
2013 3
2014 1
2015 3
2016 2
2017 1
2019 2
2020 6
2021 5
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.
Coleman RL, Lorusso D, Gennigens C, González-Martín A, Randall L, Cibula D, Lund B, Woelber L, Pignata S, Forget F, Redondo A, Vindeløv SD, Chen M, Harris JR, Smith M, Nicacio LV, Teng MSL, Laenen A, Rangwala R, Manso L, Mirza M, Monk BJ, Vergote I; innovaTV 204/GOG-3023/ENGOT-cx6 Collaborators. Coleman RL, et al. Among authors: gennigens c. Lancet Oncol. 2021 May;22(5):609-619. doi: 10.1016/S1470-2045(21)00056-5. Epub 2021 Apr 9. Lancet Oncol. 2021. PMID: 33845034 Clinical Trial.
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer.
Hong DS, Concin N, Vergote I, de Bono JS, Slomovitz BM, Drew Y, Arkenau HT, Machiels JP, Spicer JF, Jones R, Forster MD, Cornez N, Gennigens C, Johnson ML, Thistlethwaite FC, Rangwala RA, Ghatta S, Windfeld K, Harris JR, Lassen UN, Coleman RL. Hong DS, et al. Among authors: gennigens c. Clin Cancer Res. 2020 Mar 15;26(6):1220-1228. doi: 10.1158/1078-0432.CCR-19-2962. Epub 2019 Dec 3. Clin Cancer Res. 2020. PMID: 31796521 Free article. Clinical Trial.
[Locally-advanced cervix cancer : multidisciplinary management].
Lapaille L, De Cuypere M, Goffin F, Kakkos A, Gonne E, Hermesse J, Lovinfosse P, Delbecque K, Thille A, Kridelka F, Gennigens C. Lapaille L, et al. Among authors: gennigens c. Rev Med Liege. 2021 May;76(5-6):507-514. Rev Med Liege. 2021. PMID: 34080388 Free article. French.
Optimal treatment in locally advanced cervical cancer.
Gennigens C, De Cuypere M, Hermesse J, Kridelka F, Jerusalem G. Gennigens C, et al. Expert Rev Anticancer Ther. 2021 Jun;21(6):657-671. doi: 10.1080/14737140.2021.1879646. Epub 2021 Mar 11. Expert Rev Anticancer Ther. 2021. PMID: 33472018 Free article.
[Does Radiotherapy have a role in end-of-life care?].
Barthelemy N, Jansen N, Gennigens C, Delgaudine M, Coucke PA. Barthelemy N, et al. Among authors: gennigens c. Rev Med Liege. 2012 Mar;67(3):128-32. Rev Med Liege. 2012. PMID: 22611828 Free article. Review. French.
[Management of febrile neutropenia in cancer patients].
Freres P, Gonne E, Collignon J, Giot JB, Gennigens C, Jerusalem G. Freres P, et al. Among authors: gennigens c. Rev Med Liege. 2015 Apr;70(4):195-200. Rev Med Liege. 2015. PMID: 26054171 Free article. Review. French.
[Aseptic loosening after knee mega-prostheses].
Mettlen C, Gennigens C, Kurth W. Mettlen C, et al. Among authors: gennigens c. Rev Med Liege. 2022 Jan;77(1):5-7. Rev Med Liege. 2022. PMID: 35029333 French.
Treatment algorithm in patients with ovarian cancer.
Vergote I, Denys H, De Greve J, Gennigens C, Van De Vijver K, Kerger J, Vuylsteke P, Baurain JF. Vergote I, et al. Among authors: gennigens c. Facts Views Vis Obgyn. 2020 Oct 8;12(3):227-239. Facts Views Vis Obgyn. 2020. PMID: 33123697 Free PMC article.
[Peritoneal carcinomatosis of unknown origin].
Marchal N, Gennigens C, Jerusalem G. Marchal N, et al. Among authors: gennigens c. Rev Med Liege. 2012 Nov;67(11):582-6. Rev Med Liege. 2012. PMID: 23346828 Free article. Review. French.
39 results